Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area

British Journal of Ophthalmology

Volumn 83, Issue 12, 1999, Pages 1332-1335

  Chern, Kenneth C ^a   Shrestha, S K ^b   Cevallos, Vicky ^a   Dhami, H L ^b   Tiwari, Pawan ^b   Chern, Laurie ^c   Whitcher, John P ^a   Lietman, Thomas M ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Lumbini Rana Ambika Eye Hospital   (Nepal)

^c UPMC St Margaret Hospital   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERIUM CULTURE; CHILD; CHLAMYDIA TRACHOMATIS; CONJUNCTIVA; CONTROLLED STUDY; ENDEMIC DISEASE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NEPAL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STREPTOCOCCUS; TRACHOMA; WORLD HEALTH ORGANIZATION;

EID: 0032748618     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.12.1332     Document Type: Article

References (21)

1. World Health Organisation. Report of the first meeting of the WHO alliance for the global elimination of trachoma. Geneva: WHO, 1997.
2. Bailey RL, Arullendran P, Whittle HC, et al. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993;342:453-6.
3. De Sole G. Elimination of trachoma: follow up (letter). Br J Ophthalmol 1998;82:590.
4. Thylefors B. A global initiative for the elimination of avoidable blindness. Am J Ophthalmol 1998;125:90-3.
5. Brilliant G. The epidemiology of blindness in Nepal: report of the 1981 Nepal blindness survey. Chelsea, MI: Seva Fondationa, 1988.
6. Lietman T, Dhital S, Dena D. Conjunctival impression cytology for vitamin A deficiency in the presence of infectious trachoma. Br J Ophthalmol 1998;82:1139-42.
7. Lode H, Borner K, Koeppe P, et al. Azithromycin - review of key chemical, pharmacokinetic and microbiological features. J Antimicrob Chemother 1996;37(Suppl C)1.
8. Tabbara K, al-Kharashi S, al-Mansouri S, et al. Ocular levels of azithromycin. Arch Ophthalmol 1998;116:1 625-8.
9. Karma P, Pukander J, Penttilä M. Azithromycin concentrations in sinus fluid and mucosa after oral administration. Eur J Clin Microbiol Infect Dis 1991;10:856-9.
10. Wildfeuer A, Laufen H, Zimmermann T. Distribution of orally administered azithromycin in various blood compartments. Int J Clin Pharmacol Ther 1994;32:356-60.
11. Karcioglu ZA, El-Yazigi A, Jabak MH, et al. Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels. Ophthalmology 1998;105:658-61.
12. Vaudaux BP, Cherpillod J, Dayer P. Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients. J Antimicrob Chemother 1996;37(Suppl C):45-51.
13. Tabbara KF, Abu-el-Asrar A, al-Omar O, et al. Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. Ophthalmology 1996;103:842-6.
14. Thylefors B, Dawson CR, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987;65:477-83.
15. Smolin G, Tabbara K, Whitcher J. Infectious diseases of the eye. Baltimore: Williams and Wilkins, 1984.
16. Adegbola RA, Mulholland EK, Bailey R, et al. Effect of azithromycin on pharyngeal microflora (letter). Pediatr Infect Dis J 1995;14:335-7.
17. Leach AJ, Shelby-James TM, Mayo M, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 1997;24:356-62.
18. Whitcher JP, Dawson CR, Messadi M, et al. Severe endemic trachoma in Tunisia: changes in ocular bacterial pathogens in children treated by the intermittent antibiotic regimen. Revue Internationale du Trachome (International Review of Trachoma) 1974;51:49-58.
19. Peterson J, Treadway G. Impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae (letter). Clin Infect Dis 1998;26:248-9.
20. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial. N Engl J Med 1997;337:441-6.
21. Stewart FM, Antia R, Levin BR, et al. The population genetics of antibiotic resistance. II: Analytic theory for sustained populations of bacteria in a community of hosts. Theor Popul Biol 1998;53:152-65.